J. Fortuny

First name

J.

Last name

Fortuny

Margulis, A. V., Fortuny, J., Kaye, J. A., Calingaert, B., Reynolds, M., Plana, E., et al. (2018). Value of Free-text Comments for Validating Cancer Cases Using Primary-care Data in the United Kingdom. Epidemiology. http://doi.org/10.1097/ede.0000000000000856

View

Kaye, J. A., Margulis, A. V., Fortuny, J., McQuay, L. J., Plana, E., Bartsch, J. L., et al. (2017). Cancer Incidence after Initiation of Antimuscarinic Medications for Overactive Bladder in the United Kingdom: Evidence for Protopathic Bias. Pharmacotherapy. http://doi.org/10.1002/phar.1932

View

Margulis, A. V., Fortuny, J., Kaye, J. A., Calingaert, B., Reynolds, M., Plana, E., et al. (2018). Validation of Cancer Cases Using Primary Care, Cancer Registry, and Hospitalization Data in the United Kingdom. Epidemiology. http://doi.org/10.1097/ede.0000000000000786

View

Fortuny, J., Gilsenan, A., Cainzos-Achirica, M., Cantero, O. F., Flynn, R. W. V., Garcia-Rodriguez, L., et al. (2019). Study Design and Cohort Comparability in a Study of Major Cardiovascular Events in New Users of Prucalopride Versus Polyethylene Glycol 3350. Drug Saf. http://doi.org/10.1007/s40264-019-00836-z

View

Gilsenan, A., Fortuny, J., Cainzos-Achirica, M., Cantero, O. F., Flynn, R. W. V., Garcia-Rodriguez, L., et al. (2019). Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort Study. Drug Saf. http://doi.org/10.1007/s40264-019-00835-0

View

Fortuny, J., Plana, E., & Kaye, J. A. (2021). Serum lipid trajectories in the years before a lymphoma diagnosis. Leuk Lymphoma. http://doi.org/10.1080/10428194.2021.1992618

View

Ruigomez, A., Plana, E., Gilsenan, A., Fortuny, J., Cainzos-Achirica, M., Flynn, R. W. V., et al. (2021). Identification and Validation of Major Cardiovascular Events in the United Kingdom Data Sources Included in a Multi-database Post-authorization Safety Study of Prucalopride. Drug Saf. http://doi.org/10.1007/s40264-021-01044-4

View